MEDP(MEDP)
MEDP
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $2.77B | $2.96B | $3.21B | $3.60B | $3.73B |
| Low | $2.73B | $2.76B | $3.19B | $3.46B | $3.58B |
| High | $2.81B | $3.23B | $3.24B | $3.81B | $3.94B |
| EBITDA Avg | $744M | $793M | $862M | $966M | $1.00B |
| Low | $733M | $740M | $856M | $927M | $960M |
| High | $754M | $865M | $868M | $1.02B | $1.06B |
| EBIT Avg | $733M | $782M | $849M | $953M | $986M |
| Low | $723M | $729M | $844M | $914M | $946M |
| High | $744M | $853M | $855M | $1.01B | $1.04B |
| Net Income Avg | $503M | $539M | $605M | $682M | $714M |
| Low | $495M | $514M | $562M | $646M | $676M |
| High | $511M | $569M | $720M | $733M | $767M |
| EPS Avg | $16.99 | $18.56 | $20.73 | $23.11 | $24.17 |
| Low | $16.75 | $17.42 | $19.05 | $21.89 | $22.90 |
| High | $17.31 | $19.28 | $24.39 | $24.83 | $25.97 |
| Analysts (Rev / EPS) | 9 / 9 | 9 / 9 | 9 / 9 | 4 / 3 | 4 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $688M | $695M | $708M | $719M | $739M | $759M | $785M | $806M |
| Low | $680M | $683M | $697M | $707M | $726M | $747M | $772M | $793M |
| High | $701M | $712M | $726M | $736M | $757M | $778M | $804M | $825M |
| EBITDA Avg | $184M | $186M | $190M | $193M | $198M | $204M | $211M | $216M |
| Low | $182M | $183M | $187M | $190M | $195M | $200M | $207M | $213M |
| High | $188M | $191M | $195M | $197M | $203M | $209M | $216M | $221M |
| EBIT Avg | $182M | $184M | $187M | $190M | $195M | $201M | $208M | $213M |
| Low | $180M | $181M | $184M | $187M | $192M | $197M | $204M | $209M |
| High | $185M | $188M | $192M | $195M | $200M | $206M | $213M | $218M |
| Net Income Avg | $122M | $131M | $131M | $127M | $133M | $141M | $153M | $150M |
| Low | $121M | $128M | $128M | $124M | $130M | $138M | $150M | $147M |
| High | $123M | $135M | $135M | $131M | $137M | $146M | $158M | $155M |
| EPS Avg | $4.22 | $4.52 | $4.51 | $4.38 | $4.58 | $4.88 | $5.29 | $5.18 |
| Low | $4.17 | $4.42 | $4.42 | $4.29 | $4.48 | $4.77 | $5.18 | $5.07 |
| High | $4.26 | $4.66 | $4.66 | $4.52 | $4.72 | $5.03 | $5.46 | $5.34 |
| Analysts (Rev / EPS) | 6 / 5 | 5 / 1 | 3 / 1 | 3 / 1 | 3 / 1 | 3 / 1 | 2 / 2 | 2 / 2 |